[144] Vital Farms, Inc. SEC Filing

Rhea-AI Filing Summary

Vital Farms, Inc. is the subject of a Form 144 reporting a proposed sale of 6,086 common shares with an aggregate market value of $290,376.64, slated for sale on 08/14/2025 on Nasdaq. The filing shows these securities were acquired on 08/11/2025 as a stock bonus from Vital Farms Inc, where the holder received 18,475 shares and now proposes to sell a portion. The company has 44,685,980 shares outstanding, so the proposed sale represents approximately 0.014% of outstanding shares. The notice states there were no securities sold in the past three months by the reporting person and includes the standard representation that the seller is not aware of any undisclosed material adverse information.

Insights

Financial Analyst

Small insider sale disclosed; transaction size is immaterial to capitalization.

The Form 144 shows a proposed sale of 6,086 shares valued at $290,376.64, representing roughly 0.014% of the 44.7 million shares outstanding. The shares were acquired three days earlier as a stock bonus, and no sales by the person are reported in the prior three months. From a market-impact perspective, the size of the proposed sale is negligible relative to the company's outstanding shares and thus unlikely to move the stock. The filing does, however, provide transparency about insider liquidity activity and confirms the signer represents no undisclosed material adverse information.

Corporate Governance Expert

Disclosure aligns with Rule 144 requirements; no governance red flags visible in provided content.

The notice documents a compliant Rule 144 disclosure for a proposed sale on Nasdaq and records acquisition details (stock bonus dated 08/11/2025). The absence of reported sales in the prior three months and the included representation regarding material nonpublic information are consistent with routine compliance practice. The filing does not identify the filer details in the provided content, which limits review of beneficial ownership or officer/director status; based solely on the supplied text, there are no material governance concerns disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Vital Farms Inc	Merrill Lynch 90 S Cascade Ave 6th Floor Colorado Springs CO 80903	6086	290376.64	44685980	08/14/2025	nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	08/11/2025	stock bonus	Vital Farms Inc			18475	08/11/2025	stock bonus

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Vital Farms (VITL) Form 144 report?

The Form 144 reports a proposed sale of 6,086 common shares valued at $290,376.64, with an approximate sale date of 08/14/2025 on Nasdaq.

How were the securities acquired according to the filing?

The securities were acquired on 08/11/2025 as a stock bonus from Vital Farms Inc, with 18,475 shares received by the holder.

How large is the proposed sale relative to outstanding shares for VITL?

The company reports 44,685,980 shares outstanding; the proposed sale of 6,086 shares equals approximately 0.014% of outstanding shares.

Were any securities sold by the reporting person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Does the filing identify the filer or provide contact information?

In the provided content the specific filer name and CIK are not included; submission contact fields appear in the form but contain no substantive details in the text supplied.